The World's First Neurochemical Intelligence Coin
Own equity. Access alpha. Trade liquidity.
Investors are locked out of the neurochemical frontier (Sceletium, alkaloids, clinical data).
Supply chains are broken, information asymmetry is high, equity is illiquid.
$KZN = tokenized equity share in KannaZen Inc. + membership key to exclusive market intelligence.
Transparency, liquidity, ownership, access to unique data signals.
Data-driven insights into the neurochemical investment opportunity
ROI Projection
Target Price (258% ROI)
Conservative 5-year projection: $2.50 entry → $12.50 target based on market expansion
Market Drivers
Wellness Economy
Mental wellness surge, ESG agriculture, regulatory framework development
Competitive Edge
Extraction Tech
Proprietary extraction methods, scalable cultivation, chemotype optimization
Market Position
Target Market Cap
First-mover advantage in tokenized neurochemical intelligence space
Unprecedented growth in mental wellness and neurochemical research
Scientific backing for traditional neurochemical compounds
Legal framework enabling tokenized equity structures
Token Economics
$2.50 Entry Price
20M Total Supply